Cell-specific targeting of lipid-based carriers for ODN and DNA

被引:26
作者
Bartsch, M
Weeke-Klimp, AH
Meijer, DKF
Scherphof, GL
Kamps, JAAM
机构
[1] GUIDE, Dept Pathol & Lab Med, Med Biol Sect, NL-9713 GZ Groningen, Netherlands
[2] GUIDE, Dept Cell Biol, Sect Liposome Res, NL-9713 GZ Groningen, Netherlands
[3] GUIDE, Dept Pharmacokinet & Drug Delivery, NL-9713 GZ Groningen, Netherlands
关键词
liposomes; gene therapy; cationic lipoplexes; antisense oligonucleotides; plasmid DNA; targeted delivery;
D O I
10.1081/LPR-200064961
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is well recognized that there is an urgent need for non-toxic systemically applicable vectors for biologically active nucleotides to fully exploit the current potential of molecular medicine in gene therapy. Cell-specific targeting of non-viral lipid-based carriers for ODN and DNA is a prerequisite to attain the concentration of nucleic acids required for therapeutic efficacy in the target tissue. In this review we will address the most promising approaches to selective targeting of liposomal nucleic acid carriers in vivo. In addition, the routes of entry and intracellular processing of these carrier systems are discussed as well as physiological factors potentially interfering with the biological and/or therapeutic activity of their nucleotide pay-load.
引用
收藏
页码:59 / 92
页数:34
相关论文
共 229 条
[1]   Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides [J].
Agrawal, S .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :53-68
[2]   STABILITY OF ANTISENSE DNA OLIGODEOXYNUCLEOTIDE ANALOGS IN CELLULAR-EXTRACTS AND SERA [J].
AKHTAR, S ;
KOLE, R ;
JULIANO, RL .
LIFE SCIENCES, 1991, 49 (24) :1793-1801
[3]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[4]   Biological barriers to cellular delivery of lipid-based DNA carriers [J].
Bally, MB ;
Harvie, P ;
Wong, FMP ;
Kong, S ;
Wasan, EK ;
Reimer, DL .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 38 (03) :291-315
[5]   Optimized targeting of polyethylene glycol-stabilized anti-intercellular adhesion molecule 1 oligonucleotide/lipid particles to liver sinusoidal endothelial cells [J].
Bartsch, M ;
Weeke-Klimp, AH ;
Morselt, HWM ;
Kimpfler, A ;
Asgeirsdóttir, SA ;
Schubert, R ;
Meijer, DKF ;
Scherphof, GL ;
Kamps, JAAM .
MOLECULAR PHARMACOLOGY, 2005, 67 (03) :883-890
[6]   Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells [J].
Bartsch, M ;
Weeke-Klimp, AH ;
Meijer, DKF ;
Scherphof, GL ;
Kamps, JAAM .
PHARMACEUTICAL RESEARCH, 2002, 19 (05) :676-680
[7]  
BELIKOVA AM, 1967, TETRAHEDRON LETT, P3357
[8]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[9]   The influenza haemagglutinin-induced fusion cascade: effects of target membrane permeability changes [J].
Blumenthal, R ;
Morris, SJ .
MOLECULAR MEMBRANE BIOLOGY, 1999, 16 (01) :43-47
[10]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301